Document Type

Article

Peer Reviewed

1

Publication Date

1-1-2014

NLM Title Abbreviation

BMC Pregnancy Childbirth

Journal/Book/Conference Title

BMC Pregnancy and Childbirth

PubMed ID

25073780

DOI of Published Version

10.1186/1471-2393-14-250

Total Pages

9

Abstract

Background The objective of this study was to identify high-yield screening risk factors for detecting maternal non-medical drug use during pregnancy. Methods A four year retrospective analysis was conducted at an academic medical center. Detailed chart review of both the newborn and mother’s medical record was performed on all cases for which one or more drug(s) or metabolite(s) were identified and confirmed in meconium or urine. Results 229 (9.2%) of 2,497 meconium samples out of 7,749 live births confirmed positive for one or more non-medical drugs. History of maternal non-medical drug and/or tobacco use in pregnancy was present in 90.8% of non-medical drug use cases. Addition of social risk factors and inadequate prenatal care increased the yield to 96.9%. Conclusions Use of focused screening criteria based on specific maternal and social risk factors may detect many prenatal non-medical drug exposures.

Keywords

OAfund, Meconium drug abuse detection/testing, Urine drug abuse detection/testing, Non-medical drug use, Fetal drug exposure, Prenatal drug abuse, Substance abuse testing

Journal Article Version

Version of Record

Published Article/Book Citation

BMC Pregnancy and Childbirth 14:1 (2014) pp. 1-9. doi:10.1186/1471-2393-14-250

Rights

Copyright © 2014 Wood et al.; licensee BioMed Central Ltd.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

Included in

Pediatrics Commons

Share

COinS
 

URL

http://ir.uiowa.edu/pediatrics_pubs/1